Jingyitong is still in normal use! Who is to blame for the "outage" storm?

Reporter Xiang Yantao, trainee reporter Zhang An, He Wangjuan

The "suspension" of Beijing Medical Pass has aroused concern from all walks of life.

"In any case, the interests and convenience of patients should not be infringed upon." A regulator told the Securities Daily reporter.

Late on the night of April 19, Beijing Yihe Spring Technology Co., Ltd. (hereinafter referred to as "Yihe Spring"), the operator of Jingyitong, once again issued an announcement that under the supervision and guidance of relevant government departments, the two sides will negotiate the historical investment and future operating expenses of the online system of Jingyitong in a rational manner to promote the final solution of all problems. During the negotiation period between the two sides, the company will ensure the normal operation of the online system of Jingyitong.

The contradiction between Yihe Spring, the operating entity of Jingyitong, and the Bank of Beijing, the funding party, has been laid out. The reporter visited the office of Yihe Spring and found that it was an affiliated company. Why did a people's livelihood project that has been in operation for ten years suddenly almost "stop"? It remains a mystery.

It is still in normal use

Launched on April 21, 2012, the "Beijing Yitong" project was jointly promoted by the Beijing Municipal Health Bureau (later the "Beijing Municipal Health Commission"), the Beijing Municipal Hospital Administration and the Bank of Beijing, with functions such as online registration, offline number collection, outpatient payment, and report inquiry.

According to the introduction of Yihe Spring, the current online platform of "Jingyitong" covers more than 60,000 doctors, more than 40,000 beds, more than 3,000 clinical disciplines, and the paid user group exceeds 30 million, which has provided services for nearly 600 million+ patients and is the largest public medical online service platform in the country.

On April 18, a notice of the suspension of Jingyitong circulated on the Internet. According to the notice, the company signed by Yihe Spring said that Bank of Beijing, as the investor of the Online System of Jingyitong, repeatedly refused to fulfill its obligation to contribute, and the company alone bore the cost of hundreds of millions of yuan of the Beijing Medical Tong project for up to seven years, and due to its inability to bear the high operating costs, the Online System of Jingyitong will be officially suspended from 9 o'clock on April 20, 2022.

On April 19, the Beijing Municipal Health Commission responded that the Beijing Municipal Health Commission and the Beijing Municipal Hospital Management Center have urgently notified both sides that they will further supervise and guide the two sides to resolve disputes rationally in accordance with the law from the perspective of safeguarding the public interest, so that the general public can continue to obtain convenient online appointment services. The Bank of Beijing also responded that it will strengthen the coordination of all parties to ensure that patients seek medical treatment normally.

On April 20, the Securities Daily reporter found that the "Beijing Medical Pass" online registration system can still be used normally. The staff of Beijing Friendship Hospital also told reporters that it can be used normally at present.

As for the funds in the user's Jingyitong account, the customer service staff of Jingyitong told the "Securities Daily" reporter that users can hold personal documents and Jingyitong cards to the hospital window supported by Jingyitong to handle cash withdrawal business. However, at present, Beijing Huaxin Hospital and Beijing Longfu Hospital do not support the withdrawal business.

Who is the operator of Jingyitong?

According to Tianyan, Yihe Spring was established on September 18, 2014 with a registered capital of 50 million yuan. The business scope includes technology development, technical consultation, technical services, software development, health management (except for medical treatment activities subject to approval), etc.

The company has five major shareholders, the major shareholder and actual controller is Ma Jun, and other shareholders include Beijing Zhonghan Investment Center (limited partnership), Tianyue Investment Holdings Co., Ltd., Shanghai Investment Lhasa Investment Information Technology Co., Ltd., and Beijing Zhongyi Investment Center (limited partnership).

On April 19, a reporter from Securities Daily found that the recruitment information released by Yihe Spring on the BOSS direct recruitment platform showed that its address was 23rd Floor, Block A, Jiaming Center, Chaoyang District, Beijing. The reporter immediately rushed to the office building and found that the 23rd floor shown in the floor guide was Three Medical Interconnection (Beijing) Technology Co., Ltd. The front desk staff provided the reporter with the company's phone number, which was consistent with the Yihe Spring phone number displayed on the Tianyan check. However, the reporter repeatedly dialed and did not dial.

The picture shows the reception floor guidance of Block A of Jiaming Center Photo / Zhang Anhe Wang Juan

What is the relationship between the Three Doctors Interconnection and Yihe Spring? Why same office and same phone number?

According to the data of Tianyancha, the three medical network was established on August 26, 2019, with a registered capital of 1 million yuan, the legal representative is Li Ruochen, and the business scope includes technology development, technical consultation, and sales of medical devices. Li Ruochen was once the manager of Yihe Spring, but quit in 2017; he is also a shareholder of Tianyue Investment, a shareholder of Yihe Spring.

"Securities Daily" reporter came to the 23rd floor of Jiaming Center, and there were a small number of staff in the office who were working, but there was no company signboard. The reporter asked whether this was the operating company of "Jingyitong", and the staff immediately remained vigilant and quickly took the reporter away from the office area.

A staff member who did not want to disclose his identity told reporters: "Now is a sensitive period, from the company's point of view, it is also hoped that this matter can be resolved smoothly." Both companies and patients want to function properly. ”

An interesting thing happened: as the reporter left the floor, the "Three Doctors Interconnection (Beijing) Technology Co., Ltd." previously written on the floor guidelines had been erased.

The words of Sanyi Interconnection (Beijing) Technology Co., Ltd. on the 23rd floor have been erased Photo / Zhang Anhe Wang Juan

Who is at fault for the "suspension" of Beijing Medical Pass?

From the "suspension" to the continuation of operation, behind a storm around Beijing Medical Pass, it has also brought various questions.

"The original intention of establishing this project was public welfare or commercial, where did the construction and operating funds come from?" Who leads, approves, and is responsible? The above-mentioned regulatory authorities raised their own questions to the "Securities Daily" reporter.

"At present, the key to the problem of Beijing Medical Pass is, who will invest this money? What was the mechanism that worked in the first place? What is the nature of the operating entity? A person from a third-class hospital in Beijing told the "Securities Daily" reporter that at present, hospitals are paying more and more attention to informatization and even digital construction, but now they are facing the problem of mechanism, that is, which investment should be out of the hospital, which investment should be out of the government, and which investment should be out by enterprises.

In the industry's view, the "suspension" of Beijing Medical Pass has also exposed some problems faced in the process of hospital informatization construction.

Shi Lichen, founder of Beijing Dingchen Pharmaceutical, also told the Securities Daily reporter that Jingyitong has built functional modules such as registration, medical treatment, online payment, and follow-up in more than 30 hospitals in Beijing, which will cause chaos once it is stopped.

In the view of Pan Helin, co-director and researcher of the Digital Economy and Financial Innovation Research Center of Zhejiang University's International United Business School, the essence of the problem of Jingyitong is an internal dispute. In the future, the market-oriented medical digital platform will not necessarily be dominated by public welfare organizations, and enterprises can become the mainstay of this field.

(Edited by Qiao Chuanchuan)